Pacira BioSciences (PCRX) Return on Assets [ROA] (2011 - 2026)
Pacira BioSciences (PCRX) reported Return on Assets [ROA] of 1.19% for Q2 2026, up 9.35 percentage points from -8.16% a year earlier and up 0.78 percentage points from the prior quarter.
Pacira BioSciences (PCRX) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Pacira BioSciences posted Return on Assets [ROA] of 0.50%, up 6.87 percentage points from FY2024.
- Return on Assets [ROA] has a five-year change of -13.32 percentage points (FY2020 to FY2025).
- By year, Return on Assets [ROA] came in at -6.37% in FY2024 (-8.94 pp), 2.58% in FY2023 (+1.73 pp), 0.85% in FY2022 (-1.66 pp) and 2.51% in FY2021 (-11.32 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of -8.16% in Q2 2025 and a high of 4.59% in Q3 2021.
- Year over year, Return on Assets [ROA] has now increased in each of the last four quarters, with an average year-over-year change of -0.99 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was Q2 2026 (a gain of 9.35 percentage points); the low point was Q2 2025 (a drop of 12.10 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.42% (Q1 2026), 0.55% (Q4 2025) and 1.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn | 3.08% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.08% |
| Jun 30, 2026 | 1.19% |
| Mar 31, 2026 | 0.42% |
| Dec 31, 2025 | 0.55% |
| Sep 30, 2025 | 1.51% |
| Jun 30, 2025 | -8.16% |
| Mar 31, 2025 | -6.61% |
| Dec 31, 2024 | -6.48% |
| Sep 30, 2024 | -5.73% |
| Jun 30, 2024 | 3.94% |
| Mar 31, 2024 | 4.46% |
| Dec 31, 2023 | 2.70% |
| Sep 30, 2023 | 0.45% |
| Jun 30, 2023 | -0.30% |
| Mar 31, 2023 | -0.65% |
| Dec 31, 2022 | 0.93% |
| Sep 30, 2022 | 1.20% |
| Jun 30, 2022 | 2.16% |
| Mar 31, 2022 | 1.94% |
| Dec 31, 2021 | 2.44% |
Pacira BioSciences Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();